Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 6 minute read Pharma Industry News Why the IRX4204 research could reshape how the industry thinks about breast cancer prevention Could IRX4204 prevent aggressive breast cancers? Discover why new RXR research may reshape how the biotech industry approaches cancer prevention. bySoujanya RaviMarch 15, 2026